Recombinant
RabMAb

Anti-Cytokeratin 7 antibody [EPR1619Y] - Cytoskeleton Marker (ab68459)

Publishing research using ab68459? Please let us know so that we can cite the reference in this datasheet.

ab68459 has been referenced in 7 publications.

  • Francavilla C  et al. Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep 18:3242-3256 (2017). ICC/IF ; Human . PubMed: 28355574
  • Weisblum Y  et al. Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface. J Virol 91:N/A (2017). IHC-P . PubMed: 27974560
  • Sampaziotis F  et al. Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nat Protoc 12:814-827 (2017). PubMed: 28333915
  • Jin Z  et al. Baicalein reduces endometriosis by suppressing the viability of human endometrial stromal cells through the nuclear factor-?B pathwayin vitro. Exp Ther Med 14:2992-2998 (2017). PubMed: 28912852
  • Bartlett TE  et al. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat Commun 7:11620 (2016). IF . PubMed: 27216078
  • Hoffmann MJ  et al. The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors. Bladder Cancer 2:449-463 (2016). PubMed: 28035326
  • Tam J  et al. Reconstitution of full-thickness skin by microcolumn grafting. J Tissue Eng Regen Med N/A:N/A (2016). IHC-P ; Human . PubMed: 27296503

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up